The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
The secreted tumor-associated antigen 90K is a potent immune stimulator
Open accessAbstract
Immunization of mice with conditioned media from human breast cancer cells yielded the monoclonal antibody SP-2, which recognized an antigen of approximately 9&95 kDa.This protein, designated 90K, was found to be present in the serum of healthy individuals and at elevated levels in the serum of subpopulations of patients with various types of cancer and AIDS.Here we report the primary structure of the SP-2 antigen and demonstrate its relationship to a family of proteins which carry a scavenger receptor cysteine-rich domain.Northern blot analysis of normal tissues, primary tumors, and tumor-derived cell lines indicates a broad expression spectrum of the 9OK gene at widely varying levels.Functional characterization reveals stimulatory effects of 90K on host defense systems, such as natural killer cell and lymphokine-activated killer cell activity, and indicates that its immunostimulatory effects may be mediated through the induction of interleukin-2 and possibly other cytokines.Monoclonal antibodies (mAbs)' recognizing tumor-associated antigens (TAAs) for a number of cancer types have been reported, but the proportion of those that recognize molecules released in significant amounts into the bloodstream is small (for review, see Ref. 7).Moreover, the biological functions and possible roles of such TAAs in the context of tumor-host relationships are largely unknown.Previous studies using mAb SP-2, derived from the fusion of spleen cells of mice repeatedly immunized with conditioned medium of human breast cancer cell cultures, led to the identification of the 90K glycoprotein, which was found in both healthy individuals and at elevated Istituto Superiore di Sanita'-Project on AIDS, 1993 (Rome, Italy) (to *
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760
Self-citation
Cited by
Biomarker Discovery from Pancreatic Cancer Secretome Using a Differential Proteomic Approach
Grønborg, M., Kristiansen, T. Z., Iwahori, A., Chang, R., Reddy, R., Sato, N., Molina, H., Jensen, O. N., Hruban, R. H., Goggins, M. G., et al. (2006) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500178-mcp200 · Cited by 482
Mollenhauer, J., Wiemann, S., Scheurlen, W., Korn, B., Hayashi, Y., Wilgenbus, K. K., von Deimling, A., & Poustka, A. (1997) · Nature Genetics · doi:10.1038/ng0997-32 · Cited by 448
Le Naour, F., Hohenkirk, L., Grolleau, A., Misek, D. E., Lescure, P., Geiger, J. D., Hanash, S., & Beretta, L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100156200 · Cited by 284
Extracellular matrix proteomics identifies molecular signature of symptomatic carotid plaques
Langley, S. R., Willeit, K., Didangelos, A., Matic, L. P., Skroblin, P., Barallobre-Barreiro, J., Lengquist, M., Rungger, G., Kapustin, A., Kedenko, L., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci86924 · Cited by 174
Silverman, A. M., Nakata, R., Shimada, H., Sposto, R., & DeClerck, Y. A. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2165 · Cited by 93
Metadata
- Authors
- Ullrich, A., Sures, I., D'Egidio, M., Jallal, B., Powell, T. J., Herbst, R., Dreps, A., Azam, M., Rubinstein, M., & Natoli, C.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1994-07
- Volume
- 269
- Issue
- 28
- Pages
- 18401-18407
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1529251418
- Cited by
- 191
- References
- 1
- FWCI
- 1.86
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The secreted tumor-associated antigen 90K is a potent immune stimulator. https://app.cochat.ai/papers/10.1016/s0021-9258(17)32322-0
- The paper
- Ullrich, A., Sures, I., D'Egidio, M., Jallal, B., Powell, T. J., Herbst, R., Dreps, A., Azam, M., Rubinstein, M., & Natoli, C. (1994). The secreted tumor-associated antigen 90K is a potent immune stimulator. Journal of Biological Chemistry. https://doi.org/10.1016/s0021-9258(17)32322-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.